SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
P Anand, A Puranik, M Aravamudan… - Elife, 2020 - elifesciences.org
Molecular mimicry is an evolutionary strategy adopted by viruses to exploit the host cellular
machinery. We report that SARS-CoV-2 has evolved a unique S1/S2 cleavage site, absent in …
machinery. We report that SARS-CoV-2 has evolved a unique S1/S2 cleavage site, absent in …
[HTML][HTML] Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
A Puranik, PJ Lenehan, E Silvert, MJM Niesen… - MedRxiv, 2021 - ncbi.nlm.nih.gov
Although clinical trials and real-world studies have affirmed the effectiveness and safety of
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …
[PDF][PDF] FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
C Pawlowski, P Lenehan, A Puranik, V Agarwal… - Med, 2021 - cell.com
Background Two US Food and Drug Administration (FDA)-authorized coronavirus disease
2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)…
2019 (COVID-19) mRNA vaccines, BNT162b2 (Pfizer/BioNTech) and mRNA-1273 (Moderna)…
Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19
…, SN Hanson, MC Hedin, P Lenehan, A Puranik… - …, 2021 - thelancet.com
Background Real-world clinical data to support the use of casirivimab–imdevimab for the
treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) is needed. …
treatment of outpatients with mild to moderate coronavirus disease-19 (COVID-19) is needed. …
Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
C Pawlowski, A Puranik, H Bandi… - Scientific reports, 2021 - nature.com
Clinical studies are ongoing to assess whether existing vaccines may afford protection
against SARS-CoV-2 infection through trained immunity. In this exploratory study, we analyze …
against SARS-CoV-2 infection through trained immunity. In this exploratory study, we analyze …
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
…, S Awasthi, AJ Venkatakrishnan, S Bade, A Puranik… - Elife, 2020 - elifesciences.org
Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution
to guide clinical decision-making. Here, we use deep neural networks over an institution…
to guide clinical decision-making. Here, we use deep neural networks over an institution…
Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors
The COVID-19 pandemic demands assimilation of all biomedical knowledge to decode
mechanisms of pathogenesis. Despite the recent renaissance in neural networks, a platform for …
mechanisms of pathogenesis. Despite the recent renaissance in neural networks, a platform for …
[PDF][PDF] Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
R McMurry, P Lenehan, S Awasthi, E Silvert, A Puranik… - Med, 2021 - cell.com
Background As the coronavirus disease 2019 (COVID-19) vaccination campaign unfolds, it
is important to continuously assess the real-world safety of Food and Drug Administration (…
is important to continuously assess the real-world safety of Food and Drug Administration (…
Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19
…, PJ Lenehan, R Orenstein, A Puranik… - The Journal of …, 2021 - Am Soc Clin Investig
BACKGROUND Clinical data to support the use of bamlanivimab for the treatment of
outpatients with mild to moderate coronavirus disease-19 (COVID-19) are needed. METHODS …
outpatients with mild to moderate coronavirus disease-19 (COVID-19) are needed. METHODS …
Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
V Agarwal, AJ Venkatakrishnan, A Puranik… - Cell death …, 2020 - nature.com
Longitudinal characterization of SARS-CoV-2 PCR testing from COVID-19 patient’s nasopharynx
and its juxtaposition with blood-based IgG-seroconversion diagnostic assays is critical …
and its juxtaposition with blood-based IgG-seroconversion diagnostic assays is critical …
